SenesTech ( (SNES) ) has released its Q1 earnings. Here is a breakdown of the information SenesTech presented to its investors.
SenesTech, Inc. is a pioneering company in the field of fertility control for managing animal pest populations, known for its unique EPA-registered rodent birth control products. In its first quarter of 2025, SenesTech reported a 17% increase in revenues, reaching $485,000, with a notable 40% growth in its Evolve product line, which now accounts for 79% of total revenue. The company achieved a record gross profit margin of 64.5%, a significant improvement from 32.5% in the previous year. Despite a net loss of $1.7 million, this was a slight improvement from the $1.8 million loss in the same quarter last year. SenesTech’s strategic focus on product expansion, particularly in its Evolve Rat and Evolve Mouse lines, has driven growth. The company has seen a 107% increase in e-commerce revenue and expanded its municipal deployments in major U.S. cities such as Chicago and New York. Internationally, SenesTech has signed distribution agreements in eleven countries, with product shipments already underway in several regions. Looking ahead, SenesTech is optimistic about its path to profitability, driven by its cost optimization initiatives and the growing demand for its innovative pest control solutions. The company aims to lower its breakeven revenue threshold, bringing it closer to achieving positive cash flow.